<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31623154</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1261</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells8101261</ELocationID><Abstract><AbstractText>S100A4, belonging to a large multifunctional S100 protein family, is a Ca<sup>2+</sup>-binding protein with a significant role in stimulating the motility of cancer and immune cells, as well as in promoting pro-inflammatory properties in different cell types. In the CNS, there is limited information concerning S100A4 presence and function. In this study, we analyzed the expression of S100A4 and the effect of the S100A4 transcriptional inhibitor niclosamide in murine activated primary microglia. We found that S100A4 was strongly up-regulated in reactive microglia and that niclosamide prevented NADPH oxidase 2, mTOR (mammalian target of rapamycin), and NF-&#x3ba;B (nuclear factor-kappa B) increase, cytoskeletal rearrangements, migration, and phagocytosis. Furthermore, we found that S100A4 was significantly up-regulated in astrocytes and microglia in the spinal cord of a transgenic rat SOD1-G93A model of amyotrophic lateral sclerosis. Finally, we demonstrated the increased expression of S100A4 also in fibroblasts derived from amyotrophic lateral sclerosis (ALS) patients carrying <i>SOD1</i> pathogenic variants. These results ascribe S100A4 as a marker of microglial reactivity, suggesting the contribution of S100A4-regulated pathways to neuroinflammation, and identify niclosamide as a possible drug in the control and attenuation of reactive phenotypes of microglia, thus opening the way to further investigation for a new application in neurodegenerative conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serrano</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7622-0101</Identifier><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy. alessiaserrano@hotmail.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apolloni</LastName><ForeName>Savina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy. Savina.Apolloni@uniroma2.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy. simona.rossi@ift.cnr.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Translational Pharmacology, CNR, 00133 Rome, Italy. simona.rossi@ift.cnr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lattante</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2891-0340</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy. Serena.Lattante@unicatt.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Medicina Genomica, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy. Serena.Lattante@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabatelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy. Mario.Sabatelli@unicatt.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Clinico NEMO, 00168 Rome, Italy. Mario.Sabatelli@unicatt.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Neurologia, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy. Mario.Sabatelli@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peric</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Physiology and Biochemistry "Ivan Djaja", Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia. ebolaz@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andjus</LastName><ForeName>Pavle</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Physiology and Biochemistry "Ivan Djaja", Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia. pandjus@bio.bg.ac.rs.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michetti</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy. fabrizio.michetti@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr&#xec;</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy. lab.carri.tv@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzolino</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Translational Pharmacology, CNR, 00133 Rome, Italy. mauro.cozzolino@ift.cnr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ambrosi</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy. nadia.dambrosi@uniroma2.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071999">S100 Calcium-Binding Protein A4</NameOfSubstance></Chemical><Chemical><RegistryNumber>8KK8CQ2K8G</RegistryNumber><NameOfSubstance UI="D009534">Niclosamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009534" MajorTopicYN="N">Niclosamide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010587" MajorTopicYN="N">Phagocytosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071999" MajorTopicYN="N">S100 Calcium-Binding Protein A4</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">NF-&#x3ba;B</Keyword><Keyword MajorTopicYN="N">S100A4</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">fibroblasts</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">niclosamide</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31623154</ArticleId><ArticleId IdType="pmc">PMC6829868</ArticleId><ArticleId IdType="doi">10.3390/cells8101261</ArticleId><ArticleId IdType="pii">cells8101261</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heizmann C.W. Ca(2+)-Binding Proteins of the EF-Hand Superfamily: Diagnostic and Prognostic Biomarkers and Novel Therapeutic Targets. Springer; Berlin, Germany: 1929. pp. 157&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">30710273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambartsumian N., Klingelhofer J., Grigorian M. The Multifaceted S100A4 Protein in Cancer and Inflammation. Springer; Berlin, Germany: 1929. pp. 339&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">30710284</ArticleId></ArticleIdList></Reference><Reference><Citation>Piera-Velazquez S., Jimenez S.A. Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases. Physiol. Rev. 2019;99:1281&#x2013;1324. doi: 10.1152/physrev.00021.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00021.2018</ArticleId><ArticleId IdType="pmc">PMC6734087</ArticleId><ArticleId IdType="pubmed">30864875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Li J., Zhang J., Dai C., Liu X., Wang J., Gao Z., Guo H., Wang R., Lu S., et al. S100A4 promotes liver fibrosis via activation of hepatic stellate cells. J. Hepatol. 2015;62:156&#x2013;164. doi: 10.1016/j.jhep.2014.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2014.07.035</ArticleId><ArticleId IdType="pubmed">25111176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson W.E., Polosukhin V.V., Zoia O., Stathopoulos G.T., Han W., Plieth D., Loyd J.E., Neilson E.G., Blackwell T.S. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2005;171:899&#x2013;907. doi: 10.1164/rccm.200311-1535OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200311-1535OC</ArticleId><ArticleId IdType="pubmed">15618458</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamaki Y., Iwanaga Y., Niizuma S., Kawashima T., Kato T., Inuzuka Y., Horie T., Morooka H., Takase T., Akahashi Y., et al. Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J. Mol. Cell. Cardiol. 2013;57:72&#x2013;81. doi: 10.1016/j.yjmcc.2013.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2013.01.007</ArticleId><ArticleId IdType="pubmed">23352991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman J.E., Studentsova V., Myers M., Buckley M.R., Richards M.S., Loiselle A.E. Non-Invasive Ultrasound Quantification of Scar Tissue Volume Identifies Early Functional Changes During Tendon Healing. J. Orthop. Res. 2019;37:2476&#x2013;2485. doi: 10.1002/jor.24397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.24397</ArticleId><ArticleId IdType="pmc">PMC6816309</ArticleId><ArticleId IdType="pubmed">31231903</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei F., Qu J., Zhang M., Li Y., Zhang S. S100A4 in cancer progression and metastasis: A systematic review. Oncotarget. 2017;8:73219&#x2013;73239. doi: 10.18632/oncotarget.18016.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.18016</ArticleId><ArticleId IdType="pmc">PMC5641208</ArticleId><ArticleId IdType="pubmed">29069865</ArticleId></ArticleIdList></Reference><Reference><Citation>Burock S., Daum S., Keilholz U., Neumann K., Walther W., Stein U. Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: The NIKOLO trial. BMC Cancer. 2018;18:297. doi: 10.1186/s12885-018-4197-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-018-4197-9</ArticleId><ArticleId IdType="pmc">PMC5856000</ArticleId><ArticleId IdType="pubmed">29544454</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweizer M.T., Haugk K., McKiernan J.S., Gulati R., Cheng H.H., Maes J.L., Dumpit R.F., Nelson P.S., Montgomery B., McCune J.S., et al. A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer. PLoS ONE. 2018;13:e0198389. doi: 10.1371/journal.pone.0198389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198389</ArticleId><ArticleId IdType="pmc">PMC5983471</ArticleId><ArticleId IdType="pubmed">29856824</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.H., Dulyaninova N.G., House R.P., Almo S.C., Bresnick A.R. S100A4 regulates macrophage chemotaxis. Mol. Biol. Cell. 2010;21:2598&#x2013;2610. doi: 10.1091/mbc.e09-07-0609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e09-07-0609</ArticleId><ArticleId IdType="pmc">PMC2912347</ArticleId><ArticleId IdType="pubmed">20519440</ArticleId></ArticleIdList></Reference><Reference><Citation>Weatherly K., Bettonville M., Torres D., Kohler A., Goriely S., Braun M.Y. Functional profile of S100A4-deficient T cells. Immun. Inflamm. Dis. 2015;3:431&#x2013;444. doi: 10.1002/iid3.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.85</ArticleId><ArticleId IdType="pmc">PMC4693724</ArticleId><ArticleId IdType="pubmed">26734465</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulyaninova N.G., Ruiz P.D., Gamble M.J., Backer J.M., Bresnick A.R. S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol. Biol. Cell. 2018;29:632&#x2013;642. doi: 10.1091/mbc.E17-07-0460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-07-0460</ArticleId><ArticleId IdType="pmc">PMC6004585</ArticleId><ArticleId IdType="pubmed">29282275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriajevska M.V., Cardenas M.N., Grigorian M.S., Ambartsumian N.S., Georgiev G.P., Lukanidin E.M. Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene. J. Biol. Chem. 1994;269:19679&#x2013;19682.</Citation><ArticleIdList><ArticleId IdType="pubmed">8051043</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriajevska M., Fischer-Larsen M., Moertz E., Vorm O., Tulchinsky E., Grigorian M., Ambartsumian N., Lukanidin E. Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1) J. Biol. Chem. 2002;277:5229&#x2013;5235. doi: 10.1074/jbc.M110976200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110976200</ArticleId><ArticleId IdType="pubmed">11836260</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigorian M., Andresen S., Tulchinsky E., Kriajevska M., Carlberg C., Kruse C., Cohn M., Ambartsumian N., Christensen A., Selivanova G., et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: Functional consequences of their interaction. J. Biol. Chem. 2001;276:22699&#x2013;22708. doi: 10.1074/jbc.M010231200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M010231200</ArticleId><ArticleId IdType="pubmed">11278647</ArticleId></ArticleIdList></Reference><Reference><Citation>Biri-Kovacs B., Kiss B., Vadaszi H., Gogl G., Palfy G., Torok G., Homolya L., Bodor A., Nyitray L. Ezrin interacts with S100A4 via both its N- and C-terminal domains. PLoS ONE. 2017;12:e0177489. doi: 10.1371/journal.pone.0177489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177489</ArticleId><ArticleId IdType="pmc">PMC5426754</ArticleId><ArticleId IdType="pubmed">28493957</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandelin M., Zabihi S., Liu L., Wicher G., Kozlova E.N. Metastasis-associated S100A4 (Mts1) protein is expressed in subpopulations of sensory and autonomic neurons and in Schwann cells of the adult rat. J. Comp. Neurol. 2004;473:233&#x2013;243. doi: 10.1002/cne.20115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20115</ArticleId><ArticleId IdType="pubmed">15101091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlova E.N., Lukanidin E. Metastasis-associated mts1 (S100A4) protein is selectively expressed in white matter astrocytes and is up-regulated after peripheral nerve or dorsal root injury. Glia. 1999;27:249&#x2013;258. doi: 10.1002/(SICI)1098-1136(199909)27:3&lt;249::AID-GLIA6&gt;3.0.CO;2-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199909)27:3&lt;249::AID-GLIA6&gt;3.0.CO;2-E</ArticleId><ArticleId IdType="pubmed">10457371</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Z., Duthoit N., Wicher G., Kallskog O., Ambartsumian N., Lukanidin E., Takenaga K., Kozlova E.N. Intracellular calcium-binding protein S100A4 influences injury-induced migration of white matter astrocytes. Acta Neuropathol. 2006;111:213&#x2013;219. doi: 10.1007/s00401-005-0019-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-005-0019-7</ArticleId><ArticleId IdType="pubmed">16463066</ArticleId></ArticleIdList></Reference><Reference><Citation>Dmytriyeva O., Pankratova S., Owczarek S., Sonn K., Soroka V., Ridley C.M., Marsolais A., Lopez-Hoyos M., Ambartsumian N., Lukanidin E., et al. The metastasis-promoting S100A4 protein confers neuroprotection in brain injury. Nat. Commun. 2012;3:1197. doi: 10.1038/ncomms2202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2202</ArticleId><ArticleId IdType="pubmed">23149742</ArticleId></ArticleIdList></Reference><Reference><Citation>Novitskaya V., Grigorian M., Kriajevska M., Tarabykina S., Bronstein I., Berezin V., Bock E., Lukanidin E. Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J. Biol. Chem. 2000;275:41278&#x2013;41286. doi: 10.1074/jbc.M007058200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M007058200</ArticleId><ArticleId IdType="pubmed">11018041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen M.V., Kohler L.B., Grigorian M., Novitskaya V., Bock E., Lukanidin E., Berezin V. The Mts1/S100A4 protein is a neuroprotectant. J. Neurosci. Res. 2004;77:777&#x2013;786. doi: 10.1002/jnr.20221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20221</ArticleId><ArticleId IdType="pubmed">15334597</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Z., Forslund N., Takenaga K., Lukanidin E., Kozlova E.N. Sensory neurite outgrowth on white matter astrocytes is influenced by intracellular and extracellular S100A4 protein. J. Neurosci. Res. 2006;83:619&#x2013;626. doi: 10.1002/jnr.20743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20743</ArticleId><ArticleId IdType="pubmed">16435390</ArticleId></ArticleIdList></Reference><Reference><Citation>Takenaga K., Kozlova E.N. Role of intracellular S100A4 for migration of rat astrocytes. Glia. 2006;53:313&#x2013;321. doi: 10.1002/glia.20284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20284</ArticleId><ArticleId IdType="pubmed">16265672</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Parisi C., Pesaresi M.G., Rossi S., Carri M.T., Cozzolino M., Volonte C., D&#x2019;Ambrosi N. The NADPH oxidase pathway is dysregulated by the P2 &#xd7; 7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. J. Immunol. 2013;190:5187&#x2013;5195. doi: 10.4049/jimmunol.1203262.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203262</ArticleId><ArticleId IdType="pubmed">23589615</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Conte A., Zollino M., Luigetti M., Del Grande A., Marangi G., Romano A., Marcaccio A., Meleo E., Bisogni G., et al. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology. 2012;79:66&#x2013;72. doi: 10.1212/WNL.0b013e31825dceca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31825dceca</ArticleId><ArticleId IdType="pubmed">22722621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Colome A.M., Lee-Rivera I., Benavides-Hidalgo R., Lopez E. Paxillin: A crossroad in pathological cell migration. J. Hematol. Oncol. 2017;10:50. doi: 10.1186/s13045-017-0418-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-017-0418-y</ArticleId><ArticleId IdType="pmc">PMC5316197</ArticleId><ArticleId IdType="pubmed">28214467</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda S., Sasaki Y., Ohsawa K., Imai Y., Nakamura Y., Inoue K., Kohsaka S. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 2001;21:1975&#x2013;1982. doi: 10.1523/JNEUROSCI.21-06-01975.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-06-01975.2001</ArticleId><ArticleId IdType="pmc">PMC6762617</ArticleId><ArticleId IdType="pubmed">11245682</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolders S.M., Kessels S., Vangansewinkel T., Rigo J.M., Legendre P., Brone B. Microglia: Brain cells on the move. Prog. Neurobiol. 2019;178:101612. doi: 10.1016/j.pneurobio.2019.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.04.001</ArticleId><ArticleId IdType="pubmed">30954517</ArticleId></ArticleIdList></Reference><Reference><Citation>Borst K., Schwabenland M., Prinz M. Microglia metabolism in health and disease. Neurochem. Int. 2018;10:104331. doi: 10.1016/j.neuint.2018.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2018.11.006</ArticleId><ArticleId IdType="pubmed">30423423</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Mook R.A., Jr., Premont R.T., Wang J. Niclosamide: Beyond an antihelminthic drug. Cell Signal. 2018;41:89&#x2013;96. doi: 10.1016/j.cellsig.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2017.04.001</ArticleId><ArticleId IdType="pmc">PMC5628105</ArticleId><ArticleId IdType="pubmed">28389414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ren X.R., Piao H., Zhao S., Osada T., Premont R.T., Mook R.A., Jr., Morse M.A., Lyerly H.K., Chen W. Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy. Biochem. J. 2019;476:535&#x2013;546. doi: 10.1042/BCJ20180385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20180385</ArticleId><ArticleId IdType="pmc">PMC6643999</ArticleId><ArticleId IdType="pubmed">30635359</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano A., Donno C., Giannetti S., Peric M., Andjus P., D&#x2019;Ambrosi N., Michetti F. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1(G93A) Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes. Mediat. Inflamm. 2017;2017:1626204. doi: 10.1155/2017/1626204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1626204</ArticleId><ArticleId IdType="pmc">PMC5496121</ArticleId><ArticleId IdType="pubmed">28713206</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamenkovic S., Ducic T., Stamenkovic V., Kranz A., Andjus P.R. Imaging of glial cell morphology, SOD1 distribution and elemental composition in the brainstem and hippocampus of the ALS hSOD1(G93A) rat. Neuroscience. 2017;357:37&#x2013;55. doi: 10.1016/j.neuroscience.2017.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.05.041</ArticleId><ArticleId IdType="pubmed">28576725</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei F., Qu J., Li C., Wang X., Li Y., Zhang S. Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies. Cell Biosci. 2017;7:64. doi: 10.1186/s13578-017-0191-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-017-0191-1</ArticleId><ArticleId IdType="pmc">PMC5702147</ArticleId><ArticleId IdType="pubmed">29204268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Hou S., Gu J., Tian T., Yuan Q., Jia J., Qin Z., Chen Z. S100A4 promotes colon inflammation and colitis-associated colon tumorigenesis. Oncoimmunology. 2018;7:e1461301. doi: 10.1080/2162402X.2018.1461301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2018.1461301</ArticleId><ArticleId IdType="pmc">PMC6136879</ArticleId><ArticleId IdType="pubmed">30221056</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Q., Hou S., Zhai J., Tian T., Wu Y., Wu Z., He J., Chen Z., Zhang J. S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver. J. Mol. Med. 2019;97:1399&#x2013;1412. doi: 10.1007/s00109-019-01808-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-019-01808-7</ArticleId><ArticleId IdType="pubmed">31321478</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase-Kohn C., Wolf S., Herwig N., Mosch B., Pietzsch J. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages. Biochem. Biophys. Res. Commun. 2014;446:143&#x2013;148. doi: 10.1016/j.bbrc.2014.02.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.02.126</ArticleId><ArticleId IdType="pubmed">24613382</ArticleId></ArticleIdList></Reference><Reference><Citation>Helfman D.M. Niclosamide: An established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors. J. Natl. Cancer Inst. 2011;103:991&#x2013;992. doi: 10.1093/jnci/djr221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djr221</ArticleId><ArticleId IdType="pubmed">21685360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack U., Walther W., Scudiero D., Selby M., Kobelt D., Lemm M., Fichtner I., Schlag P.M., Shoemaker R.H., Stein U. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. J. Natl. Cancer Inst. 2011;103:1018&#x2013;1036. doi: 10.1093/jnci/djr190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djr190</ArticleId><ArticleId IdType="pubmed">21685359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadri H., Lambourne O.A., Mehellou Y. Niclosamide, a Drug with Many (Re)purposes. ChemMedChem. 2018;13:1088&#x2013;1091. doi: 10.1002/cmdc.201800100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201800100</ArticleId><ArticleId IdType="pmc">PMC7162286</ArticleId><ArticleId IdType="pubmed">29603892</ArticleId></ArticleIdList></Reference><Reference><Citation>Arend R.C., Londono-Joshi A.I., Gangrade A., Katre A.A., Kurpad C., Li Y., Samant R.S., Li P.K., Landen C.N., Yang E.S., et al. Niclosamide and its analogs are potent inhibitors of Wnt/beta-catenin, mTOR and STAT3 signaling in ovarian cancer. Oncotarget. 2016;7:86803&#x2013;86815. doi: 10.18632/oncotarget.13466.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.13466</ArticleId><ArticleId IdType="pmc">PMC5349955</ArticleId><ArticleId IdType="pubmed">27888804</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyapally R., Pulivendala G., Bale S., Godugu C. Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins &amp; Wnt/beta-catenin signaling: A drug repurposing study. Life Sci. 2019;220:8&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">30611787</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Duan L., Zou Z., Li H., Yuan S., Chen X., Zhang Y., Li X., Sun H., Zha H. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells. Int. J. Med. Sci. 2014;11:841&#x2013;849. doi: 10.7150/ijms.8128.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.8128</ArticleId><ArticleId IdType="pmc">PMC4057487</ArticleId><ArticleId IdType="pubmed">24936148</ArticleId></ArticleIdList></Reference><Reference><Citation>Donato R., Cannon B.R., Sorci G., Riuzzi F., Hsu K., Weber D.J., Geczy C.L. Functions of S100 proteins. Curr. Mol. Med. 2013;13:24&#x2013;57. doi: 10.2174/156652413804486214.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652413804486214</ArticleId><ArticleId IdType="pmc">PMC3707951</ArticleId><ArticleId IdType="pubmed">22834835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerezo L.A., Remakova M., Tomcik M., Gay S., Neidhart M., Lukanidin E., Pavelka K., Grigorian M., Vencovsky J., Senolt L. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. Rheumatology. 2014;53:1520&#x2013;1526. doi: 10.1093/rheumatology/keu031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu031</ArticleId><ArticleId IdType="pubmed">24643522</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz K.M., Nelson L.H. Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function. Front. Immunol. 2018;9:698. doi: 10.3389/fimmu.2018.00698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00698</ArticleId><ArticleId IdType="pmc">PMC5908908</ArticleId><ArticleId IdType="pubmed">29706957</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Appel S.H. Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies. Lancet Neurol. 2019;18:211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Sun Y., Ling S.C., Ferraiuolo L., McAlonis-Downes M., Zou Y., Drenner K., Wang Y., Ditsworth D., Tokunaga S., et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl. Acad. Sci. USA. 2015;112:E6993&#x2013;E7002. doi: 10.1073/pnas.1520639112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1520639112</ArticleId><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N., Schurr C., Olde Heuvel F., Tang L., Li Q., Tasdogan A., Kimbara A., Nettekoven M., Ottaviani G., Raposo C., et al. NF-kappaB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J. 2018;37:pii: e98697. doi: 10.15252/embj.201798697.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff J.R., Simpson E.P., Appel S.H. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr. Opin. Neurol. 2018;31:635&#x2013;639. doi: 10.1097/WCO.0000000000000599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Glial cells in amyotrophic lateral sclerosis. Pt BExp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A., Giacoppo S., Bramanti P., Mazzon E. NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model. Inflammation. 2018;41:93&#x2013;103. doi: 10.1007/s10753-017-0667-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0667-5</ArticleId><ArticleId IdType="pubmed">28936769</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyrat-Durebex C., Bris C., Codron P., Bocca C., Chupin S., Corcia P., Vourc&#x2019;h P., Hergesheimer R., Cassereau J., Funalot B., et al. Metabo-lipidomics of Fibroblasts and Mitochondrial-Endoplasmic Reticulum Extracts from ALS Patients Shows Alterations in Purine, Pyrimidine, Energetic, and Phospholipid Metabolisms. Mol. Neurobiol. 2019;56:5780&#x2013;5791. doi: 10.1007/s12035-019-1484-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1484-7</ArticleId><ArticleId IdType="pubmed">30680691</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Saw N.L., Vogel H., Cunnigham A.D., Shamloo M., Mochly-Rosen D. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol. Med. 2018;10:e8166. doi: 10.15252/emmm.201708166.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C., Kawamata H., Bredvik K.G., Arreguin A.J., Cajamarca S.A., Hupf J.C., Ravits J.M., Miller T.M., Maragakis N.J., Hales C.M., et al. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol. Neurodegener. 2017;12:76. doi: 10.1186/s13024-017-0217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0217-5</ArticleId><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Zollino M., Conte A., Del Grande A., Marangi G., Lucchini M., Mirabella M., Romano A., Piacentini R., Bisogni G., et al. Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations. Neurobiol. Aging. 2015;36:2005.e5&#x2013;2005.e13. doi: 10.1016/j.neurobiolaging.2015.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.009</ArticleId><ArticleId IdType="pubmed">25792239</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Conte A., Zollino M. Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin. Genet. 2013;83:408&#x2013;416. doi: 10.1111/cge.12117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.12117</ArticleId><ArticleId IdType="pubmed">23379621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>